T lymphocyte plasticity in chronic inflammatory diseases: The emerging role of the Ikaros family as a key Th17-Treg switch
dc.contributor.author | Ramón-Vázquez, Ana | en |
dc.contributor.author | Flood, Peter | en |
dc.contributor.author | Cashman, Thuy Linh | en |
dc.contributor.author | P. Patil | en |
dc.contributor.author | Ghosh, Subrata | en |
dc.contributor.funder | Science Foundation Ireland | en |
dc.date.accessioned | 2025-01-14T12:55:12Z | |
dc.date.available | 2025-01-14T12:55:12Z | |
dc.date.issued | 2024-12-30 | en |
dc.description.abstract | T helper (Th) 17 and regulatory T (Treg) cells are highly plastic CD4+ Th cell subsets, being able not only to actively adapt to their microenvironment, but also to interconvert, acquiring mixed identity markers. These phenotypic changes are underpinned by transcriptional control mechanisms, chromatin reorganization events and epigenetic modifications, that can be hereditable and stable over time. The Ikaros family of transcription factors have a predominant role in T cell subset specification through mechanisms of transcriptional program regulation that enable phenotypical diversification. They are crucial factors in maintaining Th17/Treg balance and therefore, homeostatic conditions in the tissues. However, they are also implicated in pathogenic processes, where their transcriptional repression contributes to the control of autoimmune processes. In this review, we discuss how T cell fate, specifically in humans, is regulated by the Ikaros family and its interplay with additional factors like the Notch signaling pathway, gut microbiota and myeloid-T cell interactions. Further, we highlight how the transcriptional activity of the Ikaros family impacts the course of T cell mediated chronic inflammatory diseases like rheumatoid and psoriatic arthritis, inflammatory bowel disease, systemic lupus erythematosus and multiple sclerosis. We conclude by discussing recently developed therapeutics designed to target Ikaros family members. | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Published Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.articleid | 103735 | en |
dc.identifier.citation | Ramón-Vázquez, A., Flood, P., Cashman, T. L., Patil, P. and Ghosh, S. (2024) 'T lymphocyte plasticity in chronic inflammatory diseases: The emerging role of the Ikaros family as a key Th17-Treg switch', Autoimmunity Reviews, 24(3), 103735 (13pp). https://doi.org/10.1016/j.autrev.2024.103735 | en |
dc.identifier.doi | https://doi.org/10.1016/j.autrev.2024.103735 | en |
dc.identifier.endpage | 13 | en |
dc.identifier.issn | 1568-9972 | en |
dc.identifier.issued | 3 | en |
dc.identifier.journaltitle | Autoimmunity Reviews | en |
dc.identifier.startpage | 1 | en |
dc.identifier.uri | https://hdl.handle.net/10468/16816 | |
dc.identifier.volume | 24 | en |
dc.language.iso | en | en |
dc.publisher | Elsevier B.V. | en |
dc.relation.ispartof | Autoimmunity Reviews | en |
dc.relation.project | info:eu-repo/grantAgreement/SFI/SFI Research Professorship Programme/20/RP/9007/IE/Analytic Understanding of Gut Microenvironment to Enhance New Treatments (AUGMENT) Rational integration of precision nutrition, microbiome and immune response to optimise immunotherapy in IBD and other inflammatory diseases/ | en |
dc.rights | © 2025, the Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC license (https://creativecommons.org/licenses/by-nc/4.0/) | en |
dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0/ | en |
dc.subject | T cell plasticity | en |
dc.subject | Ikaros family | en |
dc.subject | Chronic inflammatory diseases | en |
dc.subject | T cell differentiation | en |
dc.subject | Transcriptional control | en |
dc.title | T lymphocyte plasticity in chronic inflammatory diseases: The emerging role of the Ikaros family as a key Th17-Treg switch | en |
dc.type | Article (peer-reviewed) | en |
oaire.citation.issue | 3 | en |
oaire.citation.volume | 24 | en |